Archives

The CDC estimates that 40.3 million individuals in America experienced Substance Use Disorder (SUD) in the year 2020. SUD, also commonly referred to as substance abuse or addiction, is a…

On April 25, the US Food and Drug Administration (FDA) granted accelerated marketing approval of Qalsody (tofersen) for the treatment of amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s…

From broken bones to broken wheelchairs, we know traveling by air can be a nightmare for people living with a disability. However, MDA and its grassroots advocates have a unique…

Megan DeJarnett is an author, speaker, disability DEI educator, and inclusion advocate. Megan lives with SMA and is the organizational founder of No Such Thing, a company with a mission…

MDA Family and Clinical Support Specialist, Jordann Hager There are exciting transitions happening at the Muscular Dystrophy Association! As we move to being in-person at MDA Care Centers again, there…

At the MDA Clinical & Scientific Conference, researchers discussed how therapy advances make newborn screening for Pompe disease even more important.

MDA Ambassador Amy Curran MDA Ambassador Amy Curran lives with GNE Myopathy. She resides in the suburbs of Philadelphia, Pennsylvania with her partner, Jon, and her dog, Lexi. She holds…

April is National Volunteer Month! As MDA celebrates a month honoring the incredible volunteers who make our mission possible, we are excited to spotlight four dedicated individuals and families from…

Elevated enzymes are a frequently encountered problem in general medical practice, but their meaning often isn’t so simple to discern. When they’re found with a neuromuscular disease, the situation can…

For those living with physical disabilities, accessibility is a cornerstone of inclusion. While a focus on inclusivity and diversity has become more prevalent in the last ten years, with many…